Riskpilot← Back to searchSign inGet full accessAboatox Oy
OYActiveY-tunnus 1711444-2Leppäkuja 5Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20011 employees
Revenue 2025
EUR 18K
-27% vs 2024
EBITDA margin
-53.0%
+64% vs 2024
Equity ratio
96.2%
Financial strength
Net profit 2025
EUR -18K
+34% vs 2024
| Revenue | EUR 18K | -27% |
| EBITDA | EUR -10K | +64% |
| Net profit | EUR -18K | +34% |
| Total assets | EUR 29K | -42% |
| Equity | EUR 28K | -40% |
| Employees | 1 | — |
Legal name
Aboatox Oy
Y-tunnus number
1711444-2
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. kesäkuuta 2001
Share capital
EUR 16 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on harjoittaa fysiikan, kemian, biokemian, biotekniikan ja lääketieteen alan välineiden, laitteiden, kemikaalien, tarvikkeiden ja oheismateriaalien ja kalusteiden tuotekehitystä, valmistusta, tukku- ja vähittäiskauppaa, tuontia ja vientiä sekä harjoittaa fysiikan, kemian, biokemian, biotekniikan ja lääketieteen alaan liittyvää konsultointia, koulutusta sekä muita alaa koskettavia palveluja. Lisäksi yhtiö voi harjoittaa sijoitustoimintaa osakkeilla, kiinteistöillä, lomaosuuksilla, arvoesineillä sekä harjoittaa kiinteistöjen ja edellä mainittujen alojen tavaroiden vuokrausta.
Address
Leppäkuja 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 42 | 70 | 48 | 64 | 25 | 18 |
| Staff expenses | −2 | −2 | −3 | −4 | −2 | −3 |
| EBITDA | 1 | 17 | −19 | 28 | −27 | −10 |
| Depreciation & amort. | −2 | −2 | −1 | −1 | −1 | −1 |
| EBIT | −2 | 15 | −21 | 26 | −28 | −10 |
| Net financials | −1 | −1 | −0 | −0 | −0 | 0 |
| Profit before tax | −3 | 14 | −21 | 26 | −28 | −10 |
| Tax | −0 | −0 | 1 | 1 | −0 | 8 |
| Net profit | −3 | 14 | −22 | 25 | −28 | −18 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 95 | 100 | 57 | 90 | 49 | 29 |
| Equity | 56 | 70 | 48 | 74 | 46 | 28 |
| Long-term debt | 31 | 19 | 6 | 0 | 0 | 0 |
| Short-term debt | 7 | 11 | 3 | 16 | 3 | 1 |
| Total debt | 39 | 30 | 9 | 16 | 3 | 1 |
EBITDA margin
-53.0%
This company
15.8%
Market median
-435% vs market
20202025
Equity ratio
96.2%
This company
38.2%
Market median
+152% vs market
20202025
Return on equity
-65.9%
This company
18.4%
Market median
-458% vs market
20202025
Net profit margin
-99.5%
This company
8.1%
Market median
-1328% vs market
20202025
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20202025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202025
- Annual report 2025Filed via PRH / YTJ · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via PRH / YTJ · Period 2019-04-01 – 2020-03-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HP Deputy Member | Deputy Member | 2004 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2004 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aboatox Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Harri Pekka Lappalainen | Deputy Member | 0 companies |
| Juha Olavi Lappalainen | Board of Directors | 0 companies |